HEAL initiative – discovery of biomarkers and biomarker signatures to facilitate clinical trials for pain therapeutics (UG3/UH3 clinical trial optional)

  • Start Date:

  • Deadline:

  • Agency:
    NIH: National Institute of Neurological Disorders and Stroke

Summary text: This supports research that promotes the discovery of candidate biomarkers or biomarker signatures for pain that can be used to facilitate the testing of non-opioid pain therapeutics in phase II clinical trials. Grants are worth up to USD 1.5 million in direct costs per year for up to three years and an additional USD 500,000 per year for up to two years.